526301 Stock Overview
Together with its subsidiary, provides medical diagnostic services in India.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Medinova Diagnostic Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹37.70 |
| 52 Week High | ₹64.50 |
| 52 Week Low | ₹21.90 |
| Beta | 0.46 |
| 1 Month Change | -13.53% |
| 3 Month Change | -6.68% |
| 1 Year Change | 36.94% |
| 3 Year Change | 9.28% |
| 5 Year Change | 131.57% |
| Change since IPO | 523.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526301 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 3.0% | -1.4% | -1.9% |
| 1Y | 36.9% | 39.8% | 41.0% |
Return vs Industry: 526301 underperformed the Indian Healthcare industry which returned 39.8% over the past year.
Return vs Market: 526301 underperformed the Indian Market which returned 41% over the past year.
Price Volatility
| 526301 volatility | |
|---|---|
| 526301 Average Weekly Movement | 6.9% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 526301 has not had significant price volatility in the past 3 months.
Volatility Over Time: 526301's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 64 | Sunil Kondapally | www.medinovaindia.com |
Medinova Diagnostic Services Limited, together with its subsidiary, provides medical diagnostic services in India. The company offers MRI/CT scan, digital X-ray, ultra-sonography, bone densitometry, 2D ECHO color doppler, vascular study, cardiac stress lab, ECG, EEG, biochemistry, hematology, microbiology, and histopathology services; and home visit, lab samples, reports delivery, and ambulance services. It also provides lipid, cardiac, hypertension, renal, hepatic, orthopedic, and rheumatoid profiles, as well as well women and master health checkup services.
Medinova Diagnostic Services Limited Fundamentals Summary
| 526301 fundamental statistics | |
|---|---|
| Market cap | ₹376.31m |
| Earnings (TTM) | ₹19.99m |
| Revenue (TTM) | ₹101.65m |
18.8x
P/E Ratio3.7x
P/S RatioIs 526301 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526301 income statement (TTM) | |
|---|---|
| Revenue | ₹101.65m |
| Cost of Revenue | ₹34.06m |
| Gross Profit | ₹67.60m |
| Other Expenses | ₹47.61m |
| Earnings | ₹19.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.00 |
| Gross Margin | 66.50% |
| Net Profit Margin | 19.66% |
| Debt/Equity Ratio | -160.0% |
How did 526301 perform over the long term?
See historical performance and comparison